| 000 | 01864 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516172132.0 | ||
| 264 | 0 | _c20141014 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1348-4540 | ||
| 024 | 7 |
_a10.1507/endocrj.ej13-0304 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOhta, Akio | |
| 245 | 0 | 0 |
_aEffect of insulin glargine on endogenous insulin secretion and beta-cell function in Japanese type 2 diabetic patients using oral antidiabetic drugs. _h[electronic resource] |
| 260 |
_bEndocrine journal _c2014 |
||
| 300 |
_a13-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aC-Peptide _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFasting |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aInsulin Glargine |
| 650 | 0 | 4 | _aInsulin Secretion |
| 650 | 0 | 4 |
_aInsulin, Long-Acting _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin-Secreting Cells _xdrug effects |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPostprandial Period |
| 650 | 0 | 4 |
_aSulfonylurea Compounds _xadministration & dosage |
| 700 | 1 | _aKato, Hiroyuki | |
| 700 | 1 | _aMurayama, Katura | |
| 700 | 1 | _aHashimoto, Eriko | |
| 700 | 1 | _aMurakami, Mariko | |
| 700 | 1 | _aNishine, Ami | |
| 700 | 1 | _aOhshige, Toshihiko | |
| 700 | 1 | _aSada, Yoshiyuki | |
| 700 | 1 | _aAsai, Shiko | |
| 700 | 1 | _aKawata, Takehiro | |
| 700 | 1 | _aNagai, Yoshio | |
| 700 | 1 | _aKatabami, Takuyuki | |
| 700 | 1 | _aTanaka, Yasushi | |
| 773 | 0 |
_tEndocrine journal _gvol. 61 _gno. 1 _gp. 13-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1507/endocrj.ej13-0304 _zAvailable from publisher's website |
| 999 |
_c23115557 _d23115557 |
||